本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

4.68
+0.11002.41%
盤後4.45-0.2300-4.91%19:58 EDT
成交量:7.90萬
成交額:36.36萬
市值:2,861.50萬
市盈率:-0.22
高:4.79
開:4.61
低:4.42
收:4.57
資料載入中...

公司資料

公司名字:
Aligos Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2018
員工人數:
70
公司地址:
One Corporate Drive,2nd Floor,South San Francisco,California,United States
郵編:
94080
電話:
傳真:
- -
簡介:
Aligos Therapeutics, Inc.於2018年2月5日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,專註於開發新療法,以解決肝病和病毒感染方面未滿足的醫療需求。

董事

名稱
職位
Lawrence M. Blatt
Chief Executive Officer and Director
Jack B. Nielsen
Chair and Director
Leonid Beigelman
President and Director
Carole Nuechterlein
Director
K. Peter Hirth
Director
Kathleen Sereda Glaub
Director
Peter Moldt
Director
Thomas Woiwode
Director

股東

名稱
職位
Lawrence M. Blatt
Chief Executive Officer and Director
Lesley Ann Calhoun
Executive Vice President, Chief Financial Officer
Julian A. Symons
Executive Vice President, Chief Scientific Officer
Leonid Beigelman
President and Director
Lucinda Y. Quan
Executive Vice President, Chief Business Officer and General Counsel